In this episode, Jordan Johnson, MSHA, Bridge Oncology, ABA Health Law Oncology Advocacy, discusses the major CMS policy shifts reshaping oncology, the growing role of AI governance, and why healthcare leaders must think beyond reimbursement rates to prepare for the future of care delivery. He also shares advice for entrepreneurs on building systems thinking across finance, clinical care, compliance, and technology.

The Future of Oncology Strategy, AI and CMS Reform with Jordan Johnson

Becker’s Healthcare Podcast

[SPEAKER_A] Every health system executive right now is being asked to do something that has no useful precedent: make durable technology decisions in an environment that looks meaningfully different every 6 months. The pace isn't slowing, the vendor landscape isn't getting simpler, and the cost of missteps keeps rising. Becker's 11th Annual IT and Revenue Cycle Conference: The Future of AI and Digital Health exists for exactly this challenge. Here you'll find more than 2,500 executive-level attendees, 600 100+ speakers and 4 days of sessions built around the questions leaders are actually wrestling with: how to scale AI responsibly, how to protect increasingly complex systems, how to wring more performance out of the revenue cycle, and how to make tech investments that hold up over time. Join us September 14th through the 17th at the Hilton Chicago. You can register on our events page at beckershospitalreview.com. By clicking on the events tab in the upper right.

[SPEAKER_B] This is Scott Becker with the Becker's Healthcare Podcast. We're thrilled today to be joined by a brilliant leader. We're joined today by Jordan Johnson of Bridge Oncology. Jordan's going to talk to us about the trends he's watching. Obviously, that oncology space is so challenging right now, and a lot more. Jordan, take a moment and tell us a bit about yourself and what you do.

[SPEAKER_C] Oh, you bet, Scott. Pleasure to be here and talk about some of this with all the chaos that we have going on. But my name is Jordan Johnson, and I'm the co-founder of Bridge Oncology along with Dr. Arpit Chhabra, but started my career clinically almost 20— I guess it's been 21 years ago— as a radiologic technologist doing X-ray CT, and then as a radiation therapist, then moved on into the executive leadership...

The Future of Oncology Strategy, AI and CMS Reform with Jordan Johnson

Read the full transcript

The candid version is on a podcast,
not the earnings call.

The Future of Oncology Strategy, AI and CMS Reform with Jordan Johnson

Read the full transcript

The candid version is on a podcast, not the earnings call.

The candid version is on a podcast,
not the earnings call.